DaVita Surpasses Profitability Target for Integrated Kidney Care, Outlines Aggressive 2026 Growth Plan
DaVita Inc. reported a milestone first profitable year for its Integrated Kidney Care (IKC) division, beating its own 2026 target. The kidney care giant provided robust 2026 guidance, forecasting 33% adjusted EPS growth, fueled by clinical initiatives and strategic partnerships aimed at reducing patient mortality and hospitalization rates.